NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 388 filers reported holding NEKTAR THERAPEUTICS in Q3 2018. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $289,000 | +2.1% | 16,100 | -2.4% | 0.00% | 0.0% |
| Q2 2021 | $283,000 | +11.4% | 16,500 | +29.9% | 0.00% | +50.0% |
| Q1 2021 | $254,000 | +24.5% | 12,700 | +5.8% | 0.00% | 0.0% |
| Q4 2020 | $204,000 | -14.6% | 12,000 | -16.7% | 0.00% | -33.3% |
| Q3 2020 | $239,000 | -52.0% | 14,400 | -33.0% | 0.00% | -50.0% |
| Q2 2020 | $498,000 | +35.0% | 21,500 | +3.9% | 0.01% | +20.0% |
| Q1 2020 | $369,000 | -49.5% | 20,700 | -38.8% | 0.01% | -37.5% |
| Q4 2019 | $730,000 | -1.1% | 33,800 | +179.3% | 0.01% | -11.1% |
| Q3 2018 | $738,000 | +24.9% | 12,100 | 0.0% | 0.01% | +28.6% |
| Q2 2018 | $591,000 | +122.2% | 12,100 | +384.0% | 0.01% | +133.3% |
| Q1 2018 | $266,000 | – | 2,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TIRSCHWELL & LOEWY INC | 588,908 | $7,138,000 | 1.23% |
| Granahan Investment Management | 3,693,956 | $44,771,000 | 1.21% |
| NEA Management Company, LLC | 1,825,600 | $22,126,000 | 1.09% |
| FIC CAPITAL INC | 150,868 | $1,829,000 | 0.75% |
| Rhenman & Partners Asset Management AB | 181,797 | $2,203,000 | 0.66% |
| SOPHROSYNE CAPITAL LLC | 60,200 | $728,000 | 0.64% |
| HARVEY CAPITAL MANAGEMENT INC | 130,400 | $1,580,000 | 0.63% |
| Artal Group S.A. | 1,300,000 | $15,756,000 | 0.57% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 564,418 | $6,840,000 | 0.47% |
| OppenheimerFunds, Inc. | 24,400,000 | $295,728,000 | 0.35% |